Skip to content

Evaluating the effect of photobiomodulation therapy with diode laser on peri-implant soft tissue healing following uncovering.

Evaluating the effect of photobiomodulation therapy with 445 nm diode laser on peri-implant soft tissue healing following uncovering: a triple-blind, split-mouth, randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220119053766N1
Enrollment
10
Registered
2022-03-17
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluating the effect of photobiomodulation therapy with 445 nm diode laser on peri-implant soft tissue healing following uncovering.

Interventions

Intervention 1: Intervention group:Initially, to start the process
local anesthesia with local infiltration technique in the maxilla or inferior alveolar nerve block in the mandible with 2% lidocaine anesthetic solution and epinephrine 1/100000 (Elixir Pharmaceutical

Sponsors

Tehran University of Medical Sciences- faculty of dentistry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients who have received dental implants in a two-stage (conventional) method, bilaterally in one jaw(maxilla or mandible), and need healing abutment of a same size. 2) People over 18 years old. 3) No smoking, tobacco and other tobacco and alcohol consumption in the last six months. 4) Patients who have a good oral hygiene. (Patients are evaluated with O'Leary plaque index; and plaque index less than 10% is considered as good oral hygiene). 5) bleeding score less than 25% in 6 areas of each tooth 6) No history of periodontal treatment in the surgical area in the past year.

Exclusion criteria

Exclusion criteria: 1) Patients with uncontrolled systemic disease (uncontrolled diabetes, immunodeficiency and uncontrolled periodontal disease). 2) Pregnant and lactating women. 3) People allergic to the drugs used in the study. 4) History of IV bisphosphonates consumption during the past three years and oral mode over ten years. 5) History of radiotherapy and chemotherapy in the head and neck area. 6) People who need advanced soft tissue management procedures (patients who have soft tissue defects or have extra soft tissue in the area). 7) Candidates of fresh socket implant method.

Design outcomes

Primary

MeasureTime frame
Early Wound Healing Score (EHS). Timepoint: Days 3, 7, 14 before the laser and also in the 21st day session. Method of measurement: By the Early Wound Healing Score (EHS) in the data collection form.

Secondary

MeasureTime frame
Patient evaluation of pain and discomfort in the surgical area. Timepoint: On each of the 3, 7, 14 days before the laser and also on the 21st day after surgery. Method of measurement: Assessment of pain and discomfort in the surgical area, which is scored by the patient himself with a visual analog scale in the form of a 10 cm linear segment. The lowest score indicates the least pain and the highest score indicates the most pain and discomfort in the surgical area.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNima Dehghani

Tehran University of Medical Sciences- School of Dentistry

nimadt2002@yahoo.com+98 21 8801 5801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026